Health Through Evidence

Experts in Health Economics, Access, and Value Consulting
#Health_economics #HEOR #HTA

[Health Through Evidence @EvidenceThrough]

It was an honor for Health Through Evidence to collaborate with the @greek_patient on the development of the HTA Guide.

We thank them for their trust and collaboration in strengthening the patient voice in healthcare decision-making.
Link to the guide: https://t.co/zEeNkT4lRW

[Health Through Evidence @EvidenceThrough]

At the High-Level Policy Round Table “IBD Greece 2030”, held on May 19, 2026, Health Through Evidence participated in an important discussion on the future of care for patients with IBD in 🇬🇷.

Thank you to all participants for the valuable discussion focused on patients’ needs.

[Health Through Evidence @EvidenceThrough]

On #WorldIBDDay, we stand with everyone living with #IBD.

Real-world studies by @HELLESCC & HTE highlight an important reality: for many people living with IBD, the burden of disease extends far beyond clinical symptoms.

https://t.co/ZQpoXy7G5I
https://t.co/vehOQCRvyS

[Health Through Evidence @EvidenceThrough]

We are happy 🙂 to share our latest publication: “Disease Burden and Unmet Medical Need in Severe Hemophilia in Greece: Insights from Clinicians and Patients,” published in @FrontPubHealth
https://t.co/1lg5LnpdJB

[Health Through Evidence @EvidenceThrough]

The Health Through Evidence team wishes you a Merry Christmas and a Happy New Year! ✨

[Health Through Evidence @EvidenceThrough]

Last week, our team had the privilege of participating in the @ISPORorg Europe 2025 Congress in Glasgow, #Scotland. HTE proudly presented six posters, showcasing our expanding work across #RWE, #HEOR, and the role of #AI in HE.
Visit our posters at https://t.co/h6W4ABLwBt

[George Gourzoulidis @gourzou_7]

As part of the panel discussion “Real-World Impact – Mechanisms to Support HTA and Contain Access Inequalities” at the 10th Annual Health Technology Assessment Conference.
https://t.co/uKwhNHX8Wn

[Health Through Evidence @EvidenceThrough]

HTE had the pleasure of participating in and supporting the 10th HTA #conference 2025, themed “#HTA in Transition: Delivering #Value Through Inclusive Health Policies”, organized by #Health Daily and BOUSSIAS, held on September 30th in Athens, Greece. https://t.co/8B59FeTbK6

[Health Through Evidence @EvidenceThrough]

We’re happy to share that our latest study has been published in the open-access journal Medical Sciences.
📝 Title: Disease #Burden and #Unmet #Medical Needs in Patients with #Ulcerative Colitis in Greece: A Cross-Sectional #patient #Survey. https://t.co/lRBTQVBaGs

[Health Through Evidence @EvidenceThrough]

We’re happy to share our study: “#Burden of respiratory syncytial virus disease in infants and the potential value of maternal #Immunization in Greece,” published in open access journal Frontiers in Public #Health. @FrontPubHealth

🔗 Read more: https://t.co/Bx44RXBb9G

[Health Through Evidence @EvidenceThrough]

🌞 The Health Through Evidence team wishes you a Happy Summer! 🌴
As the #summer break begins, we’re taking a moment to step back, relax, and recharge.
Wishing our colleagues, #partners, and #friends a joyful and restful holiday season.💙

#HTE #HealthThroughEvidence #SummerBreak

[Health Through Evidence @EvidenceThrough]

Publication Alert! We’re excited to share our latest publication: #Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine to prevent pneumococcal disease in the Greek pediatric population published in Expert Review of Vaccines.
Read here: https://t.co/a3kKjXcvNF

[Health Through Evidence @EvidenceThrough]

Today, May 19th, we observe World Inflammatory Bowel Disease (IBD) Day,  a day to raise #awareness and understanding of a chronic condition that affects millions around the globe.
📝 Explore the full insights from recent studies: 🔗 https://t.co/DhSuWuvToJ
#IBDawareness

[Health Through Evidence @EvidenceThrough]

🌼 Happy #Easter from all of us at HTE – Health Through Evidence!🐣

As we #celebrate this season of renewal, we’re grateful for our colleagues, partners, and #friends . 🌸

May your Easter be filled with peace, joy, and a little bit of chocolate! 🍫💜

#EasterWishes #HappyEaster

[Health Through Evidence @EvidenceThrough]

We are delighted to share our latest publication: "Does #Real -World Evidence of the #Economic Burden of Lung #Cancer in Greece Exist? A Systematic Review of the Literature" in @CurrentOncology.
📖 Read the full study here: https://t.co/0GCWEJLz1b

[Health Through Evidence @EvidenceThrough]

We’re excited 😀to share our latest publication:
“#Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active #Ulcerative #Colitis in Greece” published in Value in Health Regional Issues. @ISPORJournals
Find out more at: https://t.co/zaENKuGKlp

[Health Through Evidence @EvidenceThrough]

We are delighted to share our publication,“Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from six 🏥 in🇬🇷 @CurrentOncology

[Health Through Evidence @EvidenceThrough]

Delighted to have been part of @ISPORorg conference in Barcelona, Spain! Our team proudly presented 15 research posters at #ISPOR Europe 2024, across diverse diseases. A special moment was having 3 posters rank in the top 5% 🏆
See more at our website:https://t.co/vW0eLobwmb.

[Health Through Evidence @EvidenceThrough]

We are excited 😃 to announce that HTE will be participating in the upcoming @ISPORorg conference. Our team will be presenting 15 posters covering a diverse range of diseases. We are deeply honored that 3 of our posters have been recognized as #Top 5% Finalists.

[Health Through Evidence @EvidenceThrough]

Find out more at:https://t.co/KPeG11wP9e @Vaccines_MDPI

[George Gourzoulidis @gourzou_7]

#Publication Alert: #Happy to share our most recent, #open-access publication ”#Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for #Prevention of Respiratory Syncytial Virus Among Older Adults in #Greece ” in @Vaccines_MDPI @MDPIOpenAccess